A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Viola Chen, MD
Eikon Therapeutics
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
57 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Scientia Clinical Research Ltd
Randwick, New South Wales, Australia
Active, not recruiting - Mater Cancer Care Centre, Mater Misericordiae Limited
South Brisbane, Queensland, Australia
Catherine Shannon, MDRecruiting - Gold Coast Private Hospital
Southport, Queensland, Australia
Andrea Tazbirkova, MDNot, yet, recruiting - Macquarie University
Sydney, Queensland, Australia
Dhanusha Sabanathan, MDRecruiting - Princess Alexandra Hospital
Woolloongabba, Queensland, Australia
Wen Xu, MDRecruiting - Peninsula and South Eastern Haematology and Oncology Group
Frankston, Victoria, Australia
Vinod Ganju, MDRecruiting
- Cross Cancer Institute
Edmonton, Alberta, Canada
Quincy Chu, MDRecruiting - Princess Margaret Cancer Centre-University Health Network
Toronto, Ontario, Canada
Amit Oza, MDRecruiting - Sunnybrook Research Institute
Toronto, Ontario, Canada
Rossanna Pezo, MDRecruiting
- Sun Yat-Sen University Cancer Center
Guangzhou, Guangdong, China
Jundong Li, MDRecruiting - the Fourth Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
Cuizhi Geng, MDRecruiting - Shandong Cancer Hospital
Jinan, Shandong, China
Huihui Li, MDRecruiting - Sir Run Run Shaw Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Xian Wang, MDRecruiting - Chongqing University Cancer Hospital
Chongqing, China
LI Yongsheng, MDLi Rong, MDRecruiting - Fujian Cancer Hospital
Fuzhou, China
Wu Fan, MDRecruiting - Zhejiang Cancer Hospital
Hangzhou, China
Zhu Jianqing, MDRecruiting - Fudan University Shanghai Cancer Center
Shanghai, China
Jian Zhang, MDXiaohua Wu, MDRecruiting
- Righospitalet
Copenhagen, Denmark
Martin Hoejgaard, MDRecruiting
- Hospices Civils de Lyon - Chu Lyon Sud
Pierre-Bénite, Rhone, France
Gilles Freyer, MDRecruiting - Clcc François Baclesse
Caen, France
Melanie Dos Santos, MDRecruiting - Institut Gustave Roussy
Villejuif, France
Alexandra LEARY, MDRecruiting
- Cha Bundang Medical Center, Cha University
Seongnam-si, Gyeonggi-do, South Korea
Yong Wha Moon, MDRecruiting - Gachon University - Gil Medical Center
Incheon, Namdong-gu, South Korea
Young Saing Kim, MDRecruiting - Severance Hospital, Yonsei University Health System
Seoul, South Korea
Joo Hyuk Sohn, MDRecruiting
- Hospital Universitari Parc Taulí
Sabadell, Barcelona, Spain
Enrique Gallardo, MDRecruiting - Hospital Clinico San Carlos
Madrid, Madrid, Spain
Jorge Bartolome, MDRecruiting - Clínica Universidad de Navarra - Hospital
Pamplona, Navarre, Spain
Antonio Gonzalez, MDRecruiting - Hospital del Mar
Barcelona, Spain
Maria Martinez Garcia, MDRecruiting - Vall D'Hebron Institute of Oncology
Barcelona, Spain
Elena Garralda, MDRecruiting - Fundacion Md Anderson Cancer Center
Madrid, Spain
Raul Marquez, MDRecruiting - Start Madrid Fundación Jiménez Díaz
Madrid, Spain
Bernard Doger, MDRecruiting - Start-Ciocc Hm Sanchinarro Hospital
Madrid, Spain
Ramón Yarza, MDRecruiting - Universidad de Sevilla - Hospital Universitario Virgen Macarena
Seville, Spain
Luis De La Cruz Merino, MDRecruiting - Hospital Clinico Universitario de Valencia - Incliva
Valencia, Spain
Desamparados Roda, MDRecruiting
- the University of Arizona Cancer Center
Tucson, Arizona, United States
Alejandro Recio-Boiles, MDRecruiting - University of Arkansas Winthrop P. Rockefeller Cancer Institute
Little Rock, Arkansas, United States
Michael Birrer, MDRecruiting - Hoag Health Center Irvine
Irvine, California, United States
Withdrawn - University California Irvine
Irvine, California, United States
Withdrawn - Sharp Memorial Hospital
San Diego, California, United States
Withdrawn - University of California San Francisco (ucsf)
San Francisco, California, United States
Withdrawn
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Dec 2023
- Primary completion
- 1 Jun 2027
- Completion
- 1 Dec 2027
- Last update posted
- 15 Jun 2026
- Registered enrollment
- 156
- Registry id
- NCT06253130
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.